메뉴 건너뛰기




Volumn 57, Issue 3, 2006, Pages 283-293

In-hospital and long-term prognostic value of fibrinogen, CRP, and IL-6 levels in patients with acute myocardial infarction treated with thrombolysis

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FIBRINOGEN; HEPARIN; INTERLEUKIN 6; NITRATE; STREPTOKINASE; TROPONIN T; FIBRINOLYTIC AGENT; TISSUE PLASMINOGEN ACTIVATOR;

EID: 33745530983     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/000331970605700304     Document Type: Article
Times cited : (39)

References (48)
  • 1
    • 0033552883 scopus 로고    scopus 로고
    • Atherosclerosis - An inflammatory disease
    • Ross R: Atherosclerosis - an inflammatory disease. N Engl J Med 340:115-126, 1999.
    • (1999) N Engl J Med , vol.340 , pp. 115-126
    • Ross, R.1
  • 2
    • 0025260903 scopus 로고
    • Interleukin-6 - An overview
    • Van Snick J: Interleukin-6 - an overview. Annu Rev Immunol 8:253-278, 1990.
    • (1990) Annu Rev Immunol , vol.8 , pp. 253-278
    • Van Snick, J.1
  • 3
    • 0032513756 scopus 로고    scopus 로고
    • Association of fibrinogen, C-reactive protein, albumin or leukocyte count with coronary heart disease: Meta-analyses of prospective studies
    • Danesh J, Collins R, Appleby P, et al: Association of fibrinogen, C-reactive protein, albumin or leukocyte count with coronary heart disease: Meta-analyses of prospective studies. JAMA 279:1477-1482, 1998.
    • (1998) JAMA , vol.279 , pp. 1477-1482
    • Danesh, J.1    Collins, R.2    Appleby, P.3
  • 4
    • 0027153282 scopus 로고
    • Fibrinogen as a cardiovascular risk factor: A meta-analysis and review of the literature
    • Ernst E, Resch KL: Fibrinogen as a cardiovascular risk factor: A meta-analysis and review of the literature. Ann Intern Med 118:956-963, 1993.
    • (1993) Ann Intern Med , vol.118 , pp. 956-963
    • Ernst, E.1    Resch, K.L.2
  • 5
    • 0031939624 scopus 로고    scopus 로고
    • Fibrinogen as a risk factor for coronary heart disease and mortality in middle-aged men and women
    • Woodward M, Lowe GDO, Rumley A, et al: Fibrinogen as a risk factor for coronary heart disease and mortality in middle-aged men and women. Eur Heart J 19:55-62, 1998.
    • (1998) Eur Heart J , vol.19 , pp. 55-62
    • Woodward, M.1    Lowe, G.D.O.2    Rumley, A.3
  • 6
    • 0028127942 scopus 로고
    • Fibrinogen and factor VII in the prediction of coronary risk
    • Heinrich J, Balleisen L, Schulte H, et al: Fibrinogen and factor VII in the prediction of coronary risk. Arterioscler Thromb 14:54-59, 1994.
    • (1994) Arterioscler Thromb , vol.14 , pp. 54-59
    • Heinrich, J.1    Balleisen, L.2    Schulte, H.3
  • 7
    • 0033022434 scopus 로고    scopus 로고
    • Measuring plasma fibrinogen to predict stroke and myocardial infarction. An update
    • Maresca G, Di Blasio A, Marchioli R, et al: Measuring plasma fibrinogen to predict stroke and myocardial infarction. An update. Arterioscler Thromb Vasc Biol 19:1368-1377, 1999.
    • (1999) Arterioscler Thromb Vasc Biol , vol.19 , pp. 1368-1377
    • Maresca, G.1    Di Blasio, A.2    Marchioli, R.3
  • 8
    • 0032566401 scopus 로고    scopus 로고
    • Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women
    • Ridker PM, Buring JE, Shih J, et al: Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 98:731-733, 1998.
    • (1998) Circulation , vol.98 , pp. 731-733
    • Ridker, P.M.1    Buring, J.E.2    Shih, J.3
  • 9
    • 0032923669 scopus 로고
    • C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: Results from the MONICA (monitoring Trends and Determinants in Cardiovascular disease in women)
    • Koenig W, Sund M, Frohlich M, et al: C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: Results from the MONICA (monitoring Trends and Determinants in Cardiovascular disease in women). Circulation 99:237-242, 1992.
    • (1992) Circulation , vol.99 , pp. 237-242
    • Koenig, W.1    Sund, M.2    Frohlich, M.3
  • 10
    • 0030956673 scopus 로고    scopus 로고
    • Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
    • Ridker PM, Cushman M, Stampfer MJ, et al: Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336:973-979, 1997.
    • (1997) N Engl J Med , vol.336 , pp. 973-979
    • Ridker, P.M.1    Cushman, M.2    Stampfer, M.J.3
  • 11
    • 0034681920 scopus 로고    scopus 로고
    • Plasma concentrations of interleukin-6 and the risk of future myocardial infarction among apparently healthy men
    • Ridker PM, Rifai N, Stampfer MJ, et al: Plasma concentrations of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 101:1767-1772, 2000.
    • (2000) Circulation , vol.101 , pp. 1767-1772
    • Ridker, P.M.1    Rifai, N.2    Stampfer, M.J.3
  • 12
    • 0028909230 scopus 로고
    • Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris
    • Thompson S, Kienast J, Pyke S, et al: Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med 332:635-641, 1995.
    • (1995) N Engl J Med , vol.332 , pp. 635-641
    • Thompson, S.1    Kienast, J.2    Pyke, S.3
  • 13
    • 0029915607 scopus 로고    scopus 로고
    • Fibrinogen is a predictor of mortality in coronary heart disease patients
    • Benderly M, Reischer-Reiss H, Behar S, et al: Fibrinogen is a predictor of mortality in coronary heart disease patients. Arterioscler Thromb Vasc Biol 16:351-356, 1996.
    • (1996) Arterioscler Thromb Vasc Biol , vol.16 , pp. 351-356
    • Benderly, M.1    Reischer-Reiss, H.2    Behar, S.3
  • 14
    • 0029089064 scopus 로고
    • Predictive value of hemostatic factors for sudden death in patients with stable angina pectoris
    • Benchimel D, Dartiques JF, Benchimol H, et al: Predictive value of hemostatic factors for sudden death in patients with stable angina pectoris. Am J Cardiol 76:241-244, 1995.
    • (1995) Am J Cardiol , vol.76 , pp. 241-244
    • Benchimel, D.1    Dartiques, J.F.2    Benchimol, H.3
  • 15
    • 0031454016 scopus 로고    scopus 로고
    • Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease
    • Toss H, Lindahl B, Siegbahn A, et al: Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease. Circulation 96:4204-4210, 1997.
    • (1997) Circulation , vol.96 , pp. 4204-4210
    • Toss, H.1    Lindahl, B.2    Siegbahn, A.3
  • 16
    • 0030015790 scopus 로고    scopus 로고
    • Prognostic value of plasma fibrinogen concentration in patients with unstable angina and non-Q wave myocardial infarction
    • Becker R, Cannon C, Bovill E, et al: Prognostic value of plasma fibrinogen concentration in patients with unstable angina and non-Q wave myocardial infarction. Am J Cardiol 78:142-147, 1996.
    • (1996) Am J Cardiol , vol.78 , pp. 142-147
    • Becker, R.1    Cannon, C.2    Bovill, E.3
  • 17
    • 0031454016 scopus 로고    scopus 로고
    • Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease
    • Toss H, Lindahl B, Siegbahn A, et al, for the FRISC study group: Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease. Circulation 96:4204-4210, 1997.
    • (1997) Circulation , vol.96 , pp. 4204-4210
    • Toss, H.1    Lindahl, B.2    Siegbahn, A.3
  • 18
    • 0034687438 scopus 로고    scopus 로고
    • Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Framing during instability in coronary artery disease
    • Lindahl B, Toss H, Siegbahn A, et al: Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Framing during instability in coronary artery disease. N Engl J Med 343:1139-1147, 2000.
    • (2000) N Engl J Med , vol.343 , pp. 1139-1147
    • Lindahl, B.1    Toss, H.2    Siegbahn, A.3
  • 19
    • 0033539593 scopus 로고    scopus 로고
    • Independent prognostic value of elevated C-reactive protein in unstable angina
    • Ferreiros ER, Boissonnet CP, Pizarro R, et al: Independent prognostic value of elevated C-reactive protein in unstable angina. Circulation 100:1958-1963, 1999.
    • (1999) Circulation , vol.100 , pp. 1958-1963
    • Ferreiros, E.R.1    Boissonnet, C.P.2    Pizarro, R.3
  • 20
    • 0035824178 scopus 로고    scopus 로고
    • Relationship between interleukin-6 and mortality in patients with unstable coronary artery disease
    • Lindmark E, Diderholm E, Wallentin L, et al: Relationship between interleukin-6 and mortality in patients with unstable coronary artery disease. JAMA 286:2107-2113, 2001.
    • (2001) JAMA , vol.286 , pp. 2107-2113
    • Lindmark, E.1    Diderholm, E.2    Wallentin, L.3
  • 21
    • 0029830113 scopus 로고    scopus 로고
    • Elevated levels of interleukin-6 in unstable angina
    • Biasucci LM, Vitelli A, Liuzzo G, et al: Elevated levels of interleukin-6 in unstable angina. Circulation 94:874-877, 1996.
    • (1996) Circulation , vol.94 , pp. 874-877
    • Biasucci, L.M.1    Vitelli, A.2    Liuzzo, G.3
  • 22
    • 0033609112 scopus 로고    scopus 로고
    • Increasing levels of interleukin (IL)-1Ra and IL-6 during the first 2 days of hospitalization in unstable angina are associated with increased risk of in-hospital coronary events
    • Biasucci LM, Liuzzo G, Fantuzzi G, et al: Increasing levels of interleukin (IL)-1Ra and IL-6 during the first 2 days of hospitalization in unstable angina are associated with increased risk of in-hospital coronary events. Circulation 99:2079-2084, 1999.
    • (1999) Circulation , vol.99 , pp. 2079-2084
    • Biasucci, L.M.1    Liuzzo, G.2    Fantuzzi, G.3
  • 23
    • 0021024778 scopus 로고
    • Haemostatic variables and the outcome of myocardial infarction
    • Haines A, Howarth D, North W, et al: Haemostatic variables and the outcome of myocardial infarction. Thromb Haemostas 50:800-803, 1983.
    • (1983) Thromb Haemostas , vol.50 , pp. 800-803
    • Haines, A.1    Howarth, D.2    North, W.3
  • 24
    • 0022786907 scopus 로고
    • Plasma fibrinogen and serum enzymes: Relative significance as prognostic indicator in acute myocardial infarction
    • Saxena K, Gupta B, Gopal R, et al: Plasma fibrinogen and serum enzymes: Relative significance as prognostic indicator in acute myocardial infarction. J Assoc Phys India 34:641-642, 1986.
    • (1986) J Assoc Phys India , vol.34 , pp. 641-642
    • Saxena, K.1    Gupta, B.2    Gopal, R.3
  • 25
    • 0025807795 scopus 로고
    • Are admission plasma fibrinogen levels useful in the characterization of risk groups after myocardial infarction treated with fibrinolysis?
    • Pollak H, Fischer M, Fritsch S, et al: Are admission plasma fibrinogen levels useful in the characterization of risk groups after myocardial infarction treated with fibrinolysis? Thromb Haemost 66:406-409, 1991.
    • (1991) Thromb Haemost , vol.66 , pp. 406-409
    • Pollak, H.1    Fischer, M.2    Fritsch, S.3
  • 26
    • 0042329297 scopus 로고    scopus 로고
    • Prognostic value of plasma C-reactive protein and fibrinogen determinations in patients with acute myocardial infarction treated with thrombolysis
    • Bennermo M, Held C, Hamsten A, et al: Prognostic value of plasma C-reactive protein and fibrinogen determinations in patients with acute myocardial infarction treated with thrombolysis. J Intern Med 254:244-250, 2003.
    • (2003) J Intern Med , vol.254 , pp. 244-250
    • Bennermo, M.1    Held, C.2    Hamsten, A.3
  • 27
    • 0026349401 scopus 로고
    • Acute phase reaction, infarct size and in-hospital morbidity in myocardial infarction patients treated with streptokinase or recombinant tissue-type plasminogen activator
    • Pietila K, Harmoinen A, Teppo AM: Acute phase reaction, infarct size and in-hospital morbidity in myocardial infarction patients treated with streptokinase or recombinant tissue-type plasminogen activator. Ann Med 23:529-535, 1991.
    • (1991) Ann Med , vol.23 , pp. 529-535
    • Pietila, K.1    Harmoinen, A.2    Teppo, A.M.3
  • 28
    • 0029812266 scopus 로고    scopus 로고
    • Serum C-reactive protein concentration in acute myocardial infarction and its relationship to mortality during 24 months of follow-up in patients under thrombolytic treatment
    • Pietila K, Harmoinen A, Jokinitty J, et al: Serum C-reactive protein concentration in acute myocardial infarction and its relationship to mortality during 24 months of follow-up in patients under thrombolytic treatment. Eur Heart J 17:1345-1349, 1996.
    • (1996) Eur Heart J , vol.17 , pp. 1345-1349
    • Pietila, K.1    Harmoinen, A.2    Jokinitty, J.3
  • 29
    • 0030855262 scopus 로고    scopus 로고
    • C-reactive protein as a predictor of infarct expansion and cardiac rupture after a first Q wave myocardial infarction
    • Anzai T, Yoshikawa T, Shiraki H, et al: C-reactive protein as a predictor of infarct expansion and cardiac rupture after a first Q wave myocardial infarction. Circulation 96:778-784, 1997.
    • (1997) Circulation , vol.96 , pp. 778-784
    • Anzai, T.1    Yoshikawa, T.2    Shiraki, H.3
  • 30
    • 0036850121 scopus 로고    scopus 로고
    • C-reactive protein levels on admission are associated with response to thrombolysis and prognosis after ST-segment elevation acute myocardial infarction
    • Zairis MN, Manousakis SJ, Stefanidis AS, et al: C-reactive protein levels on admission are associated with response to thrombolysis and prognosis after ST-segment elevation acute myocardial infarction. Am Heart J 144:782-789, 2002.
    • (2002) Am Heart J , vol.144 , pp. 782-789
    • Zairis, M.N.1    Manousakis, S.J.2    Stefanidis, A.S.3
  • 31
    • 0037606191 scopus 로고    scopus 로고
    • C-reactive protein in acute myocardial infarction: Association with heart failure
    • Berton G, Cordiano R, Palmieri R, et al: C-reactive protein in acute myocardial infarction: Association with heart failure. Am Heart J 145:1094-1101, 2003.
    • (2003) Am Heart J , vol.145 , pp. 1094-1101
    • Berton, G.1    Cordiano, R.2    Palmieri, R.3
  • 32
    • 2942754197 scopus 로고    scopus 로고
    • C-reactive protein increase in acute myocardial infarction
    • Dedobbeleer C, Melot C, Renard M: C-reactive protein increase in acute myocardial infarction. Acta Cardiol 59:291-296, 2004.
    • (2004) Acta Cardiol , vol.59 , pp. 291-296
    • Dedobbeleer, C.1    Melot, C.2    Renard, M.3
  • 33
    • 2342564921 scopus 로고    scopus 로고
    • Prognostic value of plasma interleukin-6 concentrations and the -174 G > C and -572 G > C promoter polymorphisms of the interleukin-6 gene in patients with acute myocardial infarction treated with thrombolysis
    • Bennermo M, Held C, Green F, et al: Prognostic value of plasma interleukin-6 concentrations and the -174 G > C and -572 G > C promoter polymorphisms of the interleukin-6 gene in patients with acute myocardial infarction treated with thrombolysis. Atherosclerosis 174:157-163, 2004.
    • (2004) Atherosclerosis , vol.174 , pp. 157-163
    • Bennermo, M.1    Held, C.2    Green, F.3
  • 34
    • 0023251258 scopus 로고
    • Intravenous streptokinase treatment and serum C-reactive protein in patients with acute myocardial infarction
    • Poyhonen L, Koskinen M, Heikkila J, et al: Intravenous streptokinase treatment and serum C-reactive protein in patients with acute myocardial infarction. Br Heart J 58:225-229, 1987.
    • (1987) Br Heart J , vol.58 , pp. 225-229
    • Poyhonen, L.1    Koskinen, M.2    Heikkila, J.3
  • 35
    • 12144286171 scopus 로고    scopus 로고
    • Activation of the contact system and inflammation after thrombolytic therapy in patients with acute myocardial infarction
    • Merlini PA, Cugno M, Rossi ML, et al: Activation of the contact system and inflammation after thrombolytic therapy in patients with acute myocardial infarction. Am J Cardiol 93:822-825, 2004.
    • (2004) Am J Cardiol , vol.93 , pp. 822-825
    • Merlini, P.A.1    Cugno, M.2    Rossi, M.L.3
  • 36
    • 0026764584 scopus 로고
    • Interleukin-6 release and the acute-phase reaction in patients with acute myocardial infarction: A pilot study
    • Sturk A, Hack CE, Aarder LA, et al: Interleukin-6 release and the acute-phase reaction in patients with acute myocardial infarction: A pilot study. J Lab Clin Med 119:574-579, 1992.
    • (1992) J Lab Clin Med , vol.119 , pp. 574-579
    • Sturk, A.1    Hack, C.E.2    Aarder, L.A.3
  • 37
    • 0027134770 scopus 로고
    • Elevated plasma interleukin-6 levels in patients with acute myocardial infarction
    • Miyao Y, Yasue H, Ogawa H, et al: Elevated plasma interleukin-6 levels in patients with acute myocardial infarction. Am Heart J 126:1299-1304, 1993.
    • (1993) Am Heart J , vol.126 , pp. 1299-1304
    • Miyao, Y.1    Yasue, H.2    Ogawa, H.3
  • 38
    • 0030884883 scopus 로고    scopus 로고
    • Interleukins 6 and 8 as mediators of acute-phase response in acute myocardial infarction
    • Pannitteri G, Marino B, Campa PP, et al: Interleukins 6 and 8 as mediators of acute-phase response in acute myocardial infarction. Am J Cardiol 80:622-625, 1997.
    • (1997) Am J Cardiol , vol.80 , pp. 622-625
    • Pannitteri, G.1    Marino, B.2    Campa, P.P.3
  • 39
    • 0026631075 scopus 로고
    • Serum interleukin-6 levels become elevated in acute myocardial infarction
    • Ikeda U, Ohkawa F, Scino Y, et al: Serum interleukin-6 levels become elevated in acute myocardial infarction. J Mol Cell Cardiol 24:579-584, 1992.
    • (1992) J Mol Cell Cardiol , vol.24 , pp. 579-584
    • Ikeda, U.1    Ohkawa, F.2    Scino, Y.3
  • 40
    • 0033797267 scopus 로고    scopus 로고
    • Dynamics of serum interleukin-6 level in patients with acute myocardial infarction
    • Kucharz EJ, Wilk T: Dynamics of serum interleukin-6 level in patients with acute myocardial infarction. Eur J Int Med 11:253-256, 2000.
    • (2000) Eur J Int Med , vol.11 , pp. 253-256
    • Kucharz, E.J.1    Wilk, T.2
  • 41
    • 0031870554 scopus 로고    scopus 로고
    • Cytokine expression increases in nonmyocytes from rats with postinfarction heart failure
    • Yue P, Massie BM, Simpson PC, et al: Cytokine expression increases in nonmyocytes from rats with postinfarction heart failure. Am J Physiol 275:250-258, 1998.
    • (1998) Am J Physiol , vol.275 , pp. 250-258
    • Yue, P.1    Massie, B.M.2    Simpson, P.C.3
  • 42
    • 0030789285 scopus 로고
    • Expression of interleukin-6 in the ventricles and coronary arteries of patients with myocardial infarction
    • Kanako K, Kanda T, Yokohama T, et al: Expression of interleukin-6 in the ventricles and coronary arteries of patients with myocardial infarction. Res Commun Mol Pathol Pharmacol 97:3-12, 1991.
    • (1991) Res Commun Mol Pathol Pharmacol , vol.97 , pp. 3-12
    • Kanako, K.1    Kanda, T.2    Yokohama, T.3
  • 44
    • 0017845129 scopus 로고
    • Control of the acute-phase response: Serum C-reactive protein kinetics after acute myocardial infarction
    • Kushner I, Broder MD, Karp D: Control of the acute-phase response: Serum C-reactive protein kinetics after acute myocardial infarction. J Clin Invest 61:235, 1978.
    • (1978) J Clin Invest , vol.61 , pp. 235
    • Kushner, I.1    Broder, M.D.2    Karp, D.3
  • 45
    • 0022576043 scopus 로고
    • Analysis of coagulation and fibrinolysis during intravenous infusion of recombinant human tissue-type plasminogen activator in patients with acute myocardial infarction
    • Collen D, Bounameaux H, DeCock F, et al: Analysis of coagulation and fibrinolysis during intravenous infusion of recombinant human tissue-type plasminogen activator in patients with acute myocardial infarction. Circulation 73:511-517, 1986.
    • (1986) Circulation , vol.73 , pp. 511-517
    • Collen, D.1    Bounameaux, H.2    DeCock, F.3
  • 46
    • 33748968192 scopus 로고    scopus 로고
    • Pharmacodynamics of thrombolysis with recombinant tissue-type plasminogen activator
    • Stump DC, Califf RM, Topol EJ, et al: Pharmacodynamics of thrombolysis with recombinant tissue-type plasminogen activator. Circulation 80:222-230, 1998.
    • (1998) Circulation , vol.80 , pp. 222-230
    • Stump, D.C.1    Califf, R.M.2    Topol, E.J.3
  • 47
    • 0020577139 scopus 로고
    • Fibrinolytic effect of intracoronary streptokinase administration in patients with acute myocardial infarction and coronary insufficiency
    • Cowley MJ, Hastillo A, Vetrovec G, et al: Fibrinolytic effect of intracoronary streptokinase administration in patients with acute myocardial infarction and coronary insufficiency. Circulation 67:1031-1038, 1983.
    • (1983) Circulation , vol.67 , pp. 1031-1038
    • Cowley, M.J.1    Hastillo, A.2    Vetrovec, G.3
  • 48
    • 0027316995 scopus 로고
    • Serum C-reactive protein and infarct size in myocardial infarcts patients with a close versus an open infarct-related coronary artery after thrombolytic therapy
    • Peitila K, Hurmoinen A, Hermens W, et al: Serum C-reactive protein and infarct size in myocardial infarcts patients with a close versus an open infarct-related coronary artery after thrombolytic therapy. Eur Heart J 14:915-919, 1993.
    • (1993) Eur Heart J , vol.14 , pp. 915-919
    • Peitila, K.1    Hurmoinen, A.2    Hermens, W.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.